Clinical Effect of Quyou Prescription in the Treatment of Persistent High-risk HPV Infectio

The Effect of Natural Molecules on HPV Infection

计划入组 106 人 · 首次发布于 2024 年 10 月 28 日

Transmission of Oncogenic HPV Infection Among Families

计划入组 700 人 · 首次发布于 2025 年 6 月 25 日

HPV infection(AstriVax)

311-HPV-1005

VLP vaccine (HPV infection)

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

United States

B. Braun Ltd. Centre of Excellence Infection Control

Merck & Co Inc

United States

Daré Bioscience Receives FDA Clearance for Phase 2 Trial of DARE-HPV, First Potential Treatment for Persistent High-Risk HPV Infection

HPV Vaccine Critical in Fight Against Infectious Disease and Cancer

FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis, Offering Hope for Rare Voice-Threatening Disease